Saturday 17 October 2026 Export KYMR’s income statement to Excel — free account

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $39.2 million, down 16.7% from fiscal 2024. In the quarter to June 2026, revenue grew 466.4%, EPS grew 34.7%, free cash flow grew 9.97% and total debt fell 62.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

104.78 3.36 −3.11%

Follow KYMR

Alert me

Market cap: $9.0B
P/E: 0.0×
Fwd P/E: −20.8×
Dividend yield: —
F-score: 4/9
Altman Z: 23.22
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	5	4	4	2	+8 more TTM periods Free account
ROE Full definition →	(24.15%)	(27.09%)	(25.78%)	(32.09%)
ROA Full definition →	(21.58%)	(24.35%)	(22.89%)	(27.62%)
ROIC Full definition →	(26.72%)	(25.22%)	(29.80%)	(46.94%)
Return on Tangible Assets Full definition →	(42.44%)	(47.99%)	(37.46%)	(58.81%)
Average Days of Receivables Full definition →	69.52	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(2.42)	(2.50)	(2.77)	(2.64)
Free Cash Flow Full definition →	(237.96)	(244.00)	(234.34)	(230.21)
Capital Expenditures Full definition →	(1.19)	(1.42)	(1.45)	(2.28)
Other line items
Cash ROIC Full definition →	(10.81%)	(11.13%)	(9.65%)	(15.84%)
Accounts Receivable Turnover Full definition →	8.71	0.00	0.00	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	357.68%	649.77%	807.34%	696.38%
Selling, General and Administrative Expense of Revenue Full definition →	72.15%	140.40%	173.90%	154.53%
Share Based Compensation of Revenue Full definition →	62.10%	119.82%	152.77%	135.48%
Interest Coverage Full definition →	(1,054.75)	(1,000.35)	(944.32)	(985.93)
Operating CF/Net income Full definition →	0.79	0.77	0.75	0.77
Depreciation/Fixed assets Full definition →	(0.03)	(0.02)	(0.01)	(0.04)
Capex/Depreciation Full definition →	1.13	1.78	2.56	1.24
Revenue per Share Full definition →	1.07	0.53	0.46	0.50
Operating CF per Share Full definition →	(2.41)	(2.49)	(2.76)	(2.61)
Capex per Share Full definition →	(0.01)	(0.01)	(0.02)	(0.03)
Capex to Sales Full definition →	0.01	0.03	0.04	0.05

Show all line items

Columns are period end dates

Stockrow Weekly